Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 08/25 04:46:10 pm
97.71 USD   +1.03%
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACE : Provides Update on Ongoing Phase 3 Program for VX-..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

S&P 500 Movers: MRO, REGN

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/22/2016 | 04:21pm CEST

In early trading on Monday, shares of Regeneron Pharmaceuticals

topped the list of the day's best performing components of the

S&P 500 index, trading up 2.1%. Year to date, Regeneron

Pharmaceuticals has lost about 24.0% of its value. And the worst

performing S&P 500 component thus far on the day is Marathon

Oil, trading down 6.5%. Marathon Oil is showing a gain of

24.7% looking at the year to date performance. Two other

components making moves today are Viacom, trading down 4.1%, and

Vertex Pharmaceuticals, trading up 2.0% on the day. For

MarketNewsVideo.com, I'm Sayoko Murase.

© BNK Invest, source Videos

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VERTEX PHARMACEUTICALS INC
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACEUTICALS INCORPORATED : Provides Update on Ongoing Phase 3 Program..
08/11 OPHTHOTECH : Announces Election of Ian F. Smith, Vertex Executive Vice President..
08/04 VERTEX PHARMACEUTICALS : Trek Therapeutics Acquires Two Antiviral Inhibitors Fro..
08/01 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
07/28 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Processes for P..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/27DJVERTEX PHARMACEUTICALS : Pharma Loss Narrows as Cystic Fibrosis Drug Sales Grow
07/27 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
07/27 VERTEX PHARMACEUTICALS : reports 2Q loss
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/23 Who's Next After Medivation?
08/19 Bayer/CRISPR Therapeutics joint venture Casebia Therapeutics establishes oper..
08/17 Prospects of cystic fibrosis candidate PTI-428 has Proteostasis on a run; sha..
08/17 Vertex Weathers Miss As Bigger Catalysts Loom
08/15 After Hours Gainers / Losers
Advertisement
Financials ($)
Sales 2016 1 769 M
EBIT 2016 271 M
Net income 2016 -65,6 M
Finance 2016 347 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017 52,25
EV / Sales 2016 13,3x
EV / Sales 2017 9,23x
Capitalization 23 963 M
More Financials
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 110 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith CFO, Executive VP & Principal Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-23.14%23 963
AMGEN, INC.5.24%127 850
GILEAD SCIENCES, INC.-20.45%106 233
CELGENE CORPORATION-7.65%85 728
REGENERON PHARMACEUTIC..-25.35%42 671
ACTELION LTD17.62%18 399
More Results